Quantcast

Latest National Multiple Sclerosis Society Stories

2010-01-22 17:27:00

FDA Approves Fampridine SR, Now Called Ampyra, to Improve Walking for People With All Types of Multiple Sclerosis NEW YORK, Jan. 22 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration has approved the marketing of Ampyra(TM) (dalfampridine, formerly known as fampridine SR, from Acorda Therapeutics) for its ability to improve walking speed in people with any type of multiple sclerosis. (Logo: http://www.newscom.com/cgi-bin/prnh/20090302/DC77093LOGO) Ampyra is the first...

2010-01-19 13:45:00

Lease for Additional 48,000 Square Feet Makes MS Research and Treatment Center Largest in the World NEW YORK, Jan. 19 /PRNewswire-USNewswire/ -- The International Multiple Sclerosis Management Practice (IMSMP), a 34,000 square foot research and treatment center dedicated to MS, today announced that it has signed a lease for an additional 48,000 square feet. This makes it the largest establishment in the world committed to discovering the cause and cure for MS. The practice expansion will...

2010-01-19 08:00:00

Patient Advocacy Partners Forge Collaboration to Fund Discovery of New Drugs that Target the Immune System NEW YORK and MILAN, Italy, Jan. 19 /PRNewswire-USNewswire/ -- Fast Forward, LLC, the commercial drug development arm of the National Multiple Sclerosis Society, and the Juvenile Diabetes Research Foundation (JDRF), the leader in research leading to a cure for type 1 diabetes in the world today announced a collaborative partnership with Axxam SpA -- a leading company in conducting...

2009-12-22 07:00:00

NEW YORK, Dec. 22 /PRNewswire/ -- 2009 saw exciting research progress, unprecedented opportunities on the horizon, and more scientists than ever working on resolving important questions. Despite the year's economic and financial challenges, the National Multiple Sclerosis Society continues to propel research forward to end MS. In 2009 the Society provided over $33.5 million to support 345 new and ongoing projects in its research portfolio, plus $1.5 million for Fast Forward, the Society's...

2009-11-17 09:02:18

Magnetic resonance images (MRI) of patients diagnosed with multiple sclerosis in childhood show that pediatric onset multiple sclerosis is more aggressive, and causes more brain lesions, than MS diagnosed in adulthood, researchers at the University at Buffalo have reported. Interestingly, however, patients with pediatric-onset MS -- which comprise up to 5 percent of total MS cases -- develop disabilities at a slower pace than patients with adult-onset MS, the data showed. "Patients with...

2009-10-15 22:38:00

Multiple Sclerosis Fundraising Event to Feature Gena Rowlands EAST BRUNSWICK, N.J., Oct. 15 /PRNewswire-USNewswire/ -- On October 17, East Brunswick native Kevin Goetz, will return home to New Jersey to host a celebrity cocktail reception at the Canoe Brook Country Club in Summit. The reception will raise money for National MS Society's New Jersey Metro Chapter In-Home Care Program that serves 14 counties in New Jersey, where it is estimated that almost 10,000 people have MS. Mr. Goetz...

2009-08-17 00:15:00

EAST HANOVER, N.J., Aug. 17 /PRNewswire/ -- The US Food and Drug Administration (FDA) has approved Extavia(R) (interferon beta-1b), the first in a new planned portfolio of multiple sclerosis (MS) medicines from Novartis to help patients manage this devastating disease. Extavia is approved by the FDA for the treatment of relapsing forms of MS to reduce the frequency of clinical exacerbations. The therapy is also indicated for patients who have experienced a first clinical episode of MS...

2009-07-27 16:00:00

INDIANAPOLIS and EDMONTON, Alberta, July 27 /PRNewswire-FirstCall/ -- Eli Lilly and Company (NYSE: LLY) and BioMS Medical Corp. (TSX: MS) today announced that dirucotide did not meet the primary endpoint of delaying disease progression, as measured by the Expanded Disability Status Scale (EDSS), during the two-year MAESTRO-01 Phase III trial in patients with secondary progressive multiple sclerosis (SPMS). In addition, there were no statistically significant differences between dirucotide...

2009-07-24 12:48:48

A collaborative group of U.S. health and computer experts say they have developed games for multiple sclerosis patients. Members of the MS Technology Collaborative say MyBrainGames, available for free at the Web site MyMSMyWay.com, will provide people living with the neurological disease an opportunity to exercise brain power. Many times our patients are doing well physically but they may still struggle with cognitive ability, Dr. Stephen Kirzinger of the University of Louisville, Ky., one...

2009-07-16 08:00:00

Gamers Engage Memory, Attention, Processing Skills NEW YORK, July 16 /PRNewswire-USNewswire/ -- The MS Technology Collaborative has created a new way for people living with multiple sclerosis (MS) to exercise their brain power. The Collaborative, an alliance of Bayer HealthCare Pharmaceuticals, Microsoft, and the National Multiple Sclerosis Society, today announced the launch of MyBrainGames, a free suite of online cognitive games for the MS community. Approximately 50 percent of...


Word of the Day
cacodemon
  • An evil spirit; a devil.
  • A nightmare.
  • In astrology, the twelfth house of a scheme or figure of the heavens: so called from its signifying dreadful things, such as secret enemies, great losses, imprisonment, etc.
'Cacodemon' comes from a Greek term meaning 'evil genius.'
Related